National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Health Disorders
Briefly

from National Institute of Mental Health (NIMH)9 months ago
The NCDDG Program aims to advance the discovery, preclinical development, and early proof of concept testing in humans of new pharmacologic and neuromodulatory approaches to treat mental disorders.
National Institute of Mental Health (NIMH)https://www.nimh.nih.gov/funding/grant-writing-and-application-process/concept-clearances/2024/national-cooperative-drug-device-discovery-development-groups-ncddg-for-the-treatment-of-mental-health-disorders
Significant advances in neuroscience, genetics, behavioral neuroscience, and technological developments provide a rich knowledge base for understanding pathophysiology and developing evidence-based pharmacotherapies for mental disorders.
National Institute of Mental Health (NIMH)https://www.nimh.nih.gov/funding/grant-writing-and-application-process/concept-clearances/2024/national-cooperative-drug-device-discovery-development-groups-ncddg-for-the-treatment-of-mental-health-disorders
Read at National Institute of Mental Health (NIMH)
#ncddg-program #neuroscience #pharmacology #mental-disorders #target-validation
[
|
]